Dirk Schürmann

Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus Infection

Florian van Bömmel, Thomas Wünsche, Stefan Mauss et al. · Hepatology · 2004 · 390 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

R. Ally, Dirk Schürmann, Wolfgang Kreisel et al. · Clinical Infectious Diseases · 2001 · 333 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 217 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

Elchonon M. Berkowitz, Graeme Moyle, Hans‐Jürgen Stellbrink et al. · The Journal of Infectious Diseases · 2014 · 214 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

SOLO

Joseph Gathe, Prudence Ive, Robin Wood et al. · AIDS · 2004 · 196 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17